Actinium Reports Promising Outcome of Actimab-A + CLAG-M Study at Prestigious Conference

Tuesday, 11 June 2024, 11:52
The recent presentation by Actinium at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting showcased the successful synergy of Actimab-A + CLAG-M in a clinical trial. The combination showed promising results, indicating a potential breakthrough in cancer treatment. This advancement marks a significant step forward in the field of nuclear medicine and molecular imaging.
https://store.livarava.com/77805115-281b-11ef-a413-9d5fa15a64d8.jpg
Actinium Reports Promising Outcome of Actimab-A + CLAG-M Study at Prestigious Conference

Actinium Announces Positive Results

The recent presentation by Actinium at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting showcased the successful synergy of Actimab-A + CLAG-M in a clinical trial.

Potential Breakthrough in Cancer Treatment

The combination showed promising results, indicating a potential breakthrough in cancer treatment.

Significant Advancement in the Field

This advancement marks a significant step forward in the field of nuclear medicine and molecular imaging.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe